FDA approves OTC Xyzal to deal with allergic reactions


February 01, 2017

1 min learn

We have been unable to course of your request. Please attempt once more later. Should you proceed to have this challenge please contact customerservice@slackinc.com.

Right this moment, Sanofi introduced that Xyzal Allergy 24HR has been permitted by the FDA for over-the-counter use to alleviate seasonal and year-round allergy signs, based on a press launch.

Xyzal is a single each day dose oral antihistamine, with an energetic ingredient of levocetirizine dihydrochloride, that relieves runny nostril, sneezing, itchy watery eyes and itching of the nostril or throat for 24-hours.

The FDA permitted two formulations of Xyzal for over-the-counter (OTC) use — 5 mg tablets for sufferers aged 6 years and older and 0.5 mg/mL oral resolution for sufferers aged 2 years and older.

“The FDA approval of Xyzal builds on our heritage of profitable Rx-to-OTC switches, and provides one other trusted choice to our current portfolio of OTC allergy drugs,” Robert Lengthy, head of North America Client Healthcare, Sanofi, mentioned within the launch. “We look ahead to making it out there to allergy victims throughout the nation, as the newest product in our rising client well being care enterprise.”

Xyzal will likely be out there in Spring 2017, based on Sanofi.

Disclosure: Robert Lengthy is head of North America Client Healthcare, Sanofi.


Supply hyperlink